Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 6;7(2):e014037.
doi: 10.1136/bmjopen-2016-014037.

Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol

Affiliations
Randomized Controlled Trial

Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol

Karen S W Chia et al. BMJ Open. .

Abstract

Introduction: Pulmonary hypertension (PH) is a potentially life-threatening condition characterised by elevated pulmonary artery pressure. Early stage PH patients are often asymptomatic. Disease progression is associated with impairment of right ventricular function and progressive dyspnoea. Current guidelines recommend exercise training (grade IIa, level B). However, many questions remain regarding the mechanisms of improvement, intensity of supervision and optimal frequency, duration and intensity of exercise. This study will assess the effect of an outpatient rehabilitation programme on haemodynamics and cardiac right ventricular function in patients with pulmonary arterial hypertension (PAH), a subgroup of PH.

Methods and analysis: This randomised controlled trial involves both a major urban tertiary and smaller regional hospital in New South Wales, Australia. The intervention will compare an outpatient rehabilitation programme with a control group (home exercise programme). Participants will be stable on oral PAH-specific therapy. The primary outcome measure will be right ventricular ejection fraction measured by cardiac MRI. Secondary outcomes will include haemodynamics measured by right heart catheterisation, endurance, functional capacity, health-related quality of life questionnaires and biomarkers of cardiac function and inflammation.

Ethics approval and dissemination: Ethical approval has been granted by St Vincent's Hospital, Sydney (HREC/14/SVH/341). Results of this study will be disseminated through presentation at scientific conferences and in scientific journals.

Trial registration number: ACTRN12615001041549; pre-results.

Keywords: Pulmonary hypertension; cardiac magnetic resonance imaging; haemodynamics; outpatient exercise training.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
ExPAH protocol: enrolment, allocation, follow-up and analysis. Participants are screened for eligibility. If eligible, once informed consent obtained, participants are then randomised to control group (home exercise) or intervention group (outpatient rehabilitation exercise programme). Participants are reviewed at weeks 12 and 26; participants who have not completed the required attendance (>70%) are recorded. Analysis of results will be both by intention-to-treat and per protocol methods. OP REH, outpatient rehabilitation programme.

References

    1. Galiè N, Humbert M, Vachiery JL et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67–119. 10.1093/eurheartj/ehv317 - DOI - PubMed
    1. Howard LS. Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease. Eur Respir Rev 2011;20:236–42. 10.1183/09059180.00006711 - DOI - PMC - PubMed
    1. Peacock AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev 2013;22:526–34. 10.1183/09059180.00006313 - DOI - PMC - PubMed
    1. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005;16:13–18. 10.1097/00019501-200502000-00003 - DOI - PubMed
    1. Corciova FC, Arsenescu-Georgescu C. Prognostic factors in pulmonary hypertension. Maedica (Buchar) 2012;7:30–7. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources